Federation Des Caisses Desjardins Du Quebec 10x Genomics, Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $21.3 Billion
- Q2 2025
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 350 shares of TXG stock, worth $4,224. This represents 0.0% of its overall portfolio holdings.
Number of Shares
350
Previous 560
37.5%
Holding current value
$4,224
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TXG
# of Institutions
333Shares Held
116MCall Options Held
442KPut Options Held
149K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl13.9MShares$168 Million1.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$150 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$77.2 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.02MShares$72.6 Million0.04% of portfolio
-
Nikko Asset Management Americas, Inc.6.01MShares$72.5 Million0.74% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.15B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...